Ligustrazine alleviates pulmonary arterial hypertension in rats by promoting the formation of myocardin transcription complex in the nucleus of pulmonary artery smooth muscle cells
Abstract Pulmonary arterial hypertension (PAH) is a pathophysiological state of abnormally elevated pulmonary arterial pressure caused by drugs, inflammation, toxins, viruses, hypoxia, and other risk factors. We studied the therapeutic effect and target of tetramethylpyrazine (tetramethylpyrazine [T...
Main Authors: | Xichao Yu, Mingjie Wu, Qinhai Meng, Weijie Zhu, Chenyan Zhang, Bowen Liu, Yuewen Qi, Shuqun Gu, Xinyu Wang, Jingli Wen, Yu Li, Xu Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.13534 |
Similar Items
-
Similar regulatory mechanisms of caveolins and cavins by myocardin family coactivators in arterial and bladder smooth muscle.
by: Baoyi Zhu, et al.
Published: (2017-01-01) -
Canagliflozin ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting pulmonary arterial smooth muscle cell proliferation
by: Luxun Tang, et al.
Published: (2023-12-01) -
Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt‐related pulmonary arterial hypertension
by: Jing‐jing Zhou, et al.
Published: (2022-10-01) -
YY1 directly interacts with myocardin to repress the triad myocardin/SRF/CArG box-mediated smooth muscle gene transcription during smooth muscle phenotypic modulation
by: Jian-Pu Zheng, et al.
Published: (2020-12-01) -
Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice
by: Lakhal-Littleton, S, et al.
Published: (2019)